Standard BioTools Cash Flow from Operating Activities 2010-2024 | LAB
Standard BioTools cash flow from operating activities from 2010 to 2024. Cash flow from operating activities can be defined as a company's cash flows from operations.
| Standard BioTools Annual Cash Flow Ops (Millions of US $) |
|
|---|---|
| 2023 | $-43 |
| 2022 | $-89 |
| 2021 | $-44 |
| 2020 | $-15 |
| 2019 | $-35 |
| 2018 | $-25 |
| 2017 | $-24 |
| 2016 | $-39 |
| 2015 | $-35 |
| 2014 | $-23 |
| 2013 | $-2 |
| 2012 | $-17 |
| 2011 | $-18 |
| 2010 | $-12 |
| 2009 | $-20 |
| Sector | Industry | Market Cap | Revenue |
|---|---|---|---|
| Medical | Medical Information Systems | $0.940B | $0.106B |
| Standard BioTools Inc. is a solution provider in health and disease using its proprietary mass cytometry and microfluidics technologies. It serves academic, government, pharmaceutical, biotechnology, plant and animal research and clinical laboratories. Standard BioTools Inc., formerly known as Fluidigm Corporation, is based in SOUTH SAN FRANCISCO, Calif. | |||
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| GE HealthCare Technologies (GEHC) | United States | $36.449B | 20.01 |
| Inspire Medical Systems (INSP) | United States | $4.716B | 0.00 |
| Hims & Hers Health (HIMS) | United States | $3.626B | 0.00 |
| Axonics (AXNX) | United States | $3.429B | 0.00 |
| Olink Holding AB (publ) (OLK) | Sweden | $2.981B | 0.00 |
| IRhythm Technologies (IRTC) | United States | $2.766B | 0.00 |
| Enovis (ENOV) | United States | $2.756B | 20.42 |
| Azenta (AZTA) | United States | $2.746B | 154.36 |
| 10x Genomics (TXG) | United States | $2.692B | 0.00 |
| Privia Health (PRVA) | United States | $2.065B | 115.40 |
| Schrodinger (SDGR) | United States | $1.597B | 0.00 |
| Omnicell (OMCL) | United States | $1.498B | 51.79 |
| Phreesia (PHR) | United States | $1.297B | 0.00 |
| Definitive Healthcare (DH) | United States | $0.663B | 0.00 |
| Fulgent Genetics (FLGT) | United States | $0.640B | 0.00 |
| Clover Health Investments (CLOV) | United States | $0.496B | 0.00 |
| Talkspace (TALK) | United States | $0.485B | 0.00 |
| Health Catalyst (HCAT) | United States | $0.397B | 0.00 |
| Pulmonx (LUNG) | United States | $0.313B | 0.00 |
| SOPHiA GENETICS SA (SOPH) | Switzerland | $0.309B | 0.00 |
| Butterfly Network (BFLY) | United States | $0.213B | 0.00 |
| Outset Medical (OM) | United States | $0.200B | 0.00 |
| P3 Health Partners (PIII) | United States | $0.187B | 0.00 |
| TruBridge (TBRG) | United States | $0.151B | 8.10 |
| American Well (AMWL) | United States | $0.128B | 0.00 |
| 111 (YI) | China | $0.103B | 0.00 |
| MSP Recovery (LIFW) | United States | $0.098B | 0.00 |
| SHL Telemedicine (SHLT) | Israel | $0.081B | 0.00 |
| HeartBeam (BEAT) | United States | $0.072B | 0.00 |
| Future Health ESG (FHLT) | United States | $0.065B | 0.00 |
| EUDA Health Holdings (EUDA) | Singapore | $0.058B | 0.00 |
| Mobile-health Network Solutions (MNDR) | Singapore | $0.057B | 0.00 |
| Augmedix (AUGX) | United States | $0.056B | 0.00 |
| Zepp Health (ZEPP) | China | $0.046B | 0.00 |
| Movano (MOVE) | United States | $0.044B | 0.00 |
| CareCloud (CCLD) | United States | $0.041B | 0.00 |
| Akili (AKLI) | United States | $0.033B | 0.00 |
| ImmunoPrecise Antibodies (IPA) | Canada | $0.029B | 0.00 |
| Bullfrog AI Holdings (BFRG) | United States | $0.023B | 0.00 |
| Streamline Health Solutions (STRM) | United States | $0.021B | 0.00 |
| Cue Health (HLTH) | United States | $0.015B | 0.00 |
| Strata Skin Sciences (SSKN) | United States | $0.014B | 0.00 |
| Biotricity (BTCY) | United States | $0.011B | 0.00 |
| Syra Health (SYRA) | United States | $0.009B | 0.00 |
| Transgenomic (PRPO) | United States | $0.009B | 0.00 |
| Predictive Oncology (POAI) | United States | $0.006B | 0.00 |
| HeartSciences (HSCS) | United States | $0.004B | 0.00 |
| Healthcare Triangle (HCTI) | United States | $0.004B | 0.00 |
| Zhongchao (ZCMD) | China | $0.003B | 0.00 |
| Tivic Health Systems (TIVC) | United States | $0.003B | 0.00 |
| Centogene (CNTG) | Germany | $0.000B | 0.00 |
| MDxHealth SA (MDXH) | Belgium | $0.000B | 0.00 |
| Nyxoah SA (NYXH) | Belgium | $0.000B | 0.00 |